IL5 and asthma: In the above-mentioned work, anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis by J.M. Oldhoff, U. Darsow, and others, the team tested the effectiveness of asthma therapy on AD patients.